Visualisation of transforming growth factor-β1, tissue kallikrein, and kinin and transforming growth factor-β receptors on human clear-cell renal carcinoma cells

References

Akita, K., Okuno, M., Enya, M., Imai, S., Moriwaki, H., Kawada, N., Suzuki, Y., and Kojima, S. (2002). Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-β. Gastroentrology123, 352–364.10.1053/gast.2002.34234Suche in Google Scholar

Ando, T., Okuda, S., Yanagida, T., and Fujishima, M. (1998). Localization of TGF-β and its receptors in the kidney. Miner. Electrolyte Metab.24, 149–153.10.1159/000057363Suche in Google Scholar

Barrack, E.R. (1997). TGF-β in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate31, 61–70.10.1002/(SICI)1097-0045(19970401)31:1<61::AID-PROS10>3.0.CO;2-MSuche in Google Scholar

Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev.44, 1–80.Suche in Google Scholar

Bhoola, K., Ramsaroop, R., Plendl, J., Cassim, B., Dlamini, Z., and Naicker, S. (2001). Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem.382, 77–89.10.1515/BC.2001.013Suche in Google Scholar

Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Suche in Google Scholar

Carroll, V.A. and Binder, B.R. (1999). The role of the plasminogen activation system in cancer. Semin. Thromb. Hemost.12, 211–217.10.1055/s-2007-994920Suche in Google Scholar

Clements, J.A. (1994). The human kallikrein gene family: a diversity of expression and function. Mol. Cell. Endocrinol.99, C1–C6.10.1016/0303-7207(94)90138-4Suche in Google Scholar

Clements, J., Hooper, J., Dong, Y., and Harvey, T. (2001). The expanded human kallikrein (KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biol. Chem.382, 5–14.10.1515/BC.2001.002Suche in Google Scholar

Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab Sci.41, 265–312.10.1080/10408360490471931Suche in Google Scholar

Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, I., and Obiezu, C.V. (2000). The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab.11, 54–60.10.1016/S1043-2760(99)00225-8Suche in Google Scholar

Dlamini, Z., Raidoo, D., and Bhoola, K. (1999). Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Immunopharmacology43, 303–310.10.1016/S0162-3109(99)00101-0Suche in Google Scholar

el-Dahr, S.S., Figueroa, C.D., Gonzalez, C.B., and Müller-Esterl, W. (1997). Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation. Kidney Int.51, 739–749.10.1038/ki.1997.105Suche in Google Scholar

Figueroa, C.D., MacIver, A.G., Mackenzie, J.C., and Bhoola, K.D. (1988). Localization of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry89, 437–442.10.1007/BF00492599Suche in Google Scholar

Govinden, R. and Bhoola, K.D. (2003). Geneology, expression, and cellular function of transforming growth factor-β. Pharmacol. Ther.98, 257–265.10.1016/S0163-7258(03)00035-4Suche in Google Scholar

Haaseman, M., Figueroa, C.D., Henderson, L., Grigoriev, S., Abd Alla, S., Gonzalez, C.B., Dunia, I., Hoebeke, J., Jarnagin, K., Cartaud, J., Bhoola, K.D., and Müller-Esterl, W. (1994). Distribution of bradykinin B2 receptors in target cells of kinin action. Visualisation of the receptor proteins in A431 cells, neutrophils and kidney sections. Braz. J. Med. Biol. Res.27, 1739–1756.Suche in Google Scholar

Lee-Chen, G.J., Liu, K.P., Lai, Y.C., Juang, H.S., Huang, S.Y., and Lin C.Y. (2004). Significance of the tissue kallikrein promoter and transforming growth factor-β1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int.65, 1467–1472.10.1111/j.1523-1755.2004.00526.xSuche in Google Scholar

MacKay, K., Kondaiah, P., Danielpour, D., Austin, H.A., and Brown, P.D. (1990). Expression of transforming growth factor-β1 and -β2 in rat glomeruli. Kidney Int.38, 1095–1100.10.1038/ki.1990.318Suche in Google Scholar

Massague, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol.6, 597–641.10.1146/annurev.cb.06.110190.003121Suche in Google Scholar

Massague, J. (1992). Receptors for the TGF-β family. Cell69, 1067–1070.10.1016/0092-8674(92)90627-OSuche in Google Scholar

Massague, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem.67, 753–759.10.1146/annurev.biochem.67.1.753Suche in Google Scholar PubMed

Massague, J. and Chen, Y.G. (2000). Controlling TFG-β signaling. Genes Dev.14, 627–644.10.1101/gad.14.6.627Suche in Google Scholar

Menke, J.G., Borkowski, J.A., Bierilo, K.K., MacNeil, T., Derrick, A.W., Schneck, K.A., Ransom, R.W., Strader, C.D., Linemeyer, D.L., and Hess, J.F. (1994). Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem.269, 21583–21586.10.1016/S0021-9258(17)31844-6Suche in Google Scholar

Naicker, S., Naidoo, S., Ramsaroop, R., Moodley, D., and Bhoola, K. (1999). Tissue kallikrein and kinins in renal disease. Immunopharmacology44, 183–192.10.1016/S0162-3109(99)00089-2Suche in Google Scholar

Naidoo, S., Ramsaroop, R.T., Naidoo, Y., and Bhoola, K.D. (1996). Status of B2 receptors in acute renal transplant kidney. Immunopharmacology33, 157–160.10.1016/0162-3109(96)00032-XSuche in Google Scholar

Parada, D., Arciniegas E., Moreira, O., and Trujillo, E. (2004). Transforming growth factor-β2 and -β3 expression in carcinoma of the prostate. Arch. Esp. Urol.57, 9399.Suche in Google Scholar

Peek, M., Moran, P., Mendoza, N., Wickramasinghe, D., and Kirchhofer, D. (2002). Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa. J. Biol. Chem.277, 47804–47809.10.1074/jbc.M209778200Suche in Google Scholar

Rahn, H.P., Angermann, A., Hektor, T., Kloppinger, M., and Kemme, M. (1992). Expression of human salivary gland kallikrein in insect cells by a baculovirus vector. Agents Actions38 (Suppl.), 66–73.10.1007/978-3-0348-7321-5_9Suche in Google Scholar

Ramsaroop, R., Naicker, S., Naicker, T., Naidoo S., and Bhoola, K.D. (1997). Tissue kallikrein in transplant kidney. Immunopharmacology36, 255–261.10.1016/S0162-3109(97)00030-1Suche in Google Scholar

Rifkin, D.B. (1997). Cross-talking proteases and matrix in the control of growth factor action. Fibrinolysis Proteolysis11, 3–9.10.1016/S0268-9499(97)80003-3Suche in Google Scholar

Rifkin, D.B., Tsuboi, R., and Mignatti, P. (1989). The role of proteases in matrix breakdown during invasion. Am. Rev. Respir. Dis.140, 1112–1113.10.1164/ajrccm/140.4.1112Suche in Google Scholar PubMed

Rifkin, D.B., Mazzieri, R., Munger, J.S., Noguera, I., and Song, J. (1999). Proteolytic control of growth factor availability. APMIS107, 80–85.10.1111/j.1699-0463.1999.tb01529.xSuche in Google Scholar PubMed

Roberts, A.B. and Sporn, M.B. (1990). The transforming growth factor-β. In: Handbook of Experimental Pharmacology: Peptide Growth Factors and their Receptors, M.B. Sporn and A.B. Roberts, eds. (Berlin, Germany: Springer-Verlag), pp. 419–472.10.1007/978-3-642-49295-2_8Suche in Google Scholar

Roberts, A.B., Anzono, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F., and Sporn, M.B. (1985). Type-β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA82, 119–123.10.1073/pnas.82.1.119Suche in Google Scholar PubMed PubMed Central

Roberts, R.A. and Gullick, W.J. (1989). Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis by expression of mutant ras oncogene. J. Cell Sci.94, 527–535.10.1242/jcs.94.3.527Suche in Google Scholar PubMed

Shankland, S.J., Pippin, J., Pichler, R.H., Gordon, K.L., Friedman, S., Gold, L.I., Johnson, R.J., and Couser, W.G. (1996). Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int.50, 116–124.10.1038/ki.1996.294Suche in Google Scholar PubMed

Sporn, M.B. and Roberts, A.B. (1990). TGF-β: problems and prospects. Cell Regul.1, 876–882.10.1091/mbc.1.12.875Suche in Google Scholar PubMed PubMed Central

Song, Q., Wang, D.Z., Harley, R.A., Chao, L., and Chao, J. (1996). Cellular localisation of low molecular weight kininogen and bradykinin B2 receptor mRNAs in human kidney. Am. J. Physiol.270, F919–F926.Suche in Google Scholar

Stravodimos, K., Constantinides, C., Manousakas, T., Pavlaki, C., Pantazopoulos, D., Glannopoulos, A., and Dimopoulos, C. (2000). Immunohistochemical expression of transforming growth factor-β1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinincopathological parameters. Anticancer Res.20, 3823–3828.Suche in Google Scholar

Steiner, M.S. and Barrack, E.R. (1992). Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol.6, 15–25.Suche in Google Scholar

Vandesande, F. (1983). Immunochemical double staining techniques. In: Immunohistochemistry, A.C. Cuello, ed. (New York, USA: John Wiley and Sons), pp. 257–273.Suche in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2000). The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-13. Genomics65, 184–194.10.1006/geno.2000.6159Suche in Google Scholar PubMed